Prot# SHP647-303: A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)

Project: Research project

Project Details

StatusActive
Effective start/end date6/12/196/12/22

Funding

  • PPD Investigator Services, LLC (Prot# SHP647-303)
  • Shire Human Genetic Therapies, Inc. (Prot# SHP647-303)